0001209191-21-040326.txt : 20210614 0001209191-21-040326.hdr.sgml : 20210614 20210614182026 ACCESSION NUMBER: 0001209191-21-040326 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210610 FILED AS OF DATE: 20210614 DATE AS OF CHANGE: 20210614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: APPLE ROBERT F CENTRAL INDEX KEY: 0001054942 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32302 FILM NUMBER: 211015995 MAIL ADDRESS: STREET 1: C/O INKLINE PHARMACEUTICAL CO INC STREET 2: SENTRY PARK EAST 1720 WALTON ROAD CITY: BLUE BELL STATE: PA ZIP: 19422 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANTARES PHARMA, INC. CENTRAL INDEX KEY: 0001016169 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411350192 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 PRINCETON SOUTH STREET 2: SUITE 300 CITY: EWING STATE: NJ ZIP: 08628 BUSINESS PHONE: 609-359-3020 MAIL ADDRESS: STREET 1: 100 PRINCETON SOUTH STREET 2: SUITE 300 CITY: EWING STATE: NJ ZIP: 08628 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC DATE OF NAME CHANGE: 20060120 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC DATE OF NAME CHANGE: 20020520 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/ DATE OF NAME CHANGE: 20010604 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-10 0 0001016169 ANTARES PHARMA, INC. ATRS 0001054942 APPLE ROBERT F C/O ANTARES PHARMA, INC. 100 PRINCETON SOUTH, SUITE 300 EWING NJ 08628 1 1 0 0 President & CEO Common Stock 2021-06-10 4 A 0 248869 4.42 A 2495839 D Common Stock 2021-06-11 4 F 0 58317 4.45 D 2437522 D Common Stock 2021-06-13 4 F 0 40892 4.45 D 2396630 D Stock Option (right to buy) 4.42 2021-06-10 4 A 0 474629 0.00 A 2031-06-10 Common Stock 474629 474629 D Represents grant of restricted stock units made under the Antares Pharma, Inc. Equity Compensation Plan. The shares vest in three equal annual installments from the date of grant. Represents the payment of tax liability using a portion of securities received from the company in connection with the vesting of a previously granted restricted stock unit award. The shares of common stock reported herein were withheld by the company to cover tax liability and not actually sold. Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan. The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date. /s/Lisa M. Kallebo as attorney-in-fact for Robert F. Apple 2021-06-14